2024-03-11 LIDR Meeting Notes

Attendees

(Bolded indicates presence at meeting)

Name

Organization

Name

Organization

Hung Luu

Children’s

Riki Merrick

Vernetzt, APHL

Andrea Pitkus

UW

Pam Banning

3M - Solventum

Xavier Gansel

Biomerieux

Amy McCormick

Epic

Dan Rutz

Epic

Rob Rae

CAP

Rob Hausam

Hausam Consulting

Sandy Jones

CDC

Stan Huff

Graphite

Ed Heierman

Abbott / IICC

Andrew Quinn

 

Laurent Lardin

Biomerieux

Anthony Killeen

UMN

Craig Collom

 

Marti Velezis

 Sonrisa / FDA

Walter Sujansky

FDA

Susan Downer

JMC

Ralf Herzog

Roche

Cornelia Felder

Roche

Daniel Golson

JMC

Andrea Prada

JMC

Maria Sagat

 CAP

Raja Cholan

FDA

Russ Ott

FDA

Akila Namasivayam

FDA

Desiree Mustaquim

CDC

Agenda and Notes

Topic

Notes

Topic

Notes

Reviewing minutes from the last call - Action Item Follow up

Call Schedule

send OOO via chat or email

LIDR Elements Discussion

 

Review LIDR White Paper

 Went over current draft of the White Paper

  • Members to Review and offer comments on draft document

  • Suggestion to collapse Functional and Non-Functional Requirements into one Requirements Section

  • Stan to further refine the Requirements section outline

  • Explicitly state that there will be some LIDR entries provided by IVD manufacturers and some entries that will be provided by LIDR Administrators such as results derived from equations (e.g., eGFR) and results with clinical context (e.g., 24-hour urine)

  • Question on how to collaborate with TEFCA Lab Tiger Team Interoperability Efforts

    • There seems to be little opportunity to influence document given cumbersome method available for providing comments

    • Lack of emphasis on the comparability of results as a interoperability barrier that needs to be addressed

    • Track work of TEFCA Tiger Team to ensure efforts are complementary and not contradictory

ACTION ITEMS

Please see the action items at top of this page - Next deliverable is White paper draft by end of this month

And we need to prioritize the use cases, so that we can finalize the requirements for the first phase of LIDR, which need to be included in the White paper

Next call

Monday 3/18/2024 9 - 10 AM ET

Adjourned

10:00 AM ET

From Chat:

https://drive.google.com/file/d/1gbg6Sx6RYeg6rTC_8ambzTV4sq56CmYK/view?usp=drive_link

Recording:

https://drive.google.com/file/d/1Y1t7-1gGEHqiD5_8g--JbFB8EVFmgxzt/view?usp=drive_link